Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 64

1.

Magnetic resonance-guided focused ultrasound thalamotomy for essential tremor: a 5-year single-center experience.

Sinai A, Nassar M, Eran A, Constantinescu M, Zaaroor M, Sprecher E, Schlesinger I.

J Neurosurg. 2019 Jul 5:1-8. doi: 10.3171/2019.3.JNS19466. [Epub ahead of print]

PMID:
31277064
2.

[EFFECT OF GENDER ON OUTCOME OF TREATMENT FOR TREMOR WITH MRI GUIDED FOCUSED ULTRASOUND].

Schlesinger I, Sinai A, Nassar M, Eran A, Zaaroor M.

Harefuah. 2019 Jun;158(6):343-346. Hebrew.

PMID:
31215183
3.

The Role of the Anesthesiologist during Magnetic Resonance-Guided Focused Ultrasound Thalamotomy for Tremor: A Single-Center Experience.

Sinai A, Katz Y, Zaaroor M, Sandler O, Schlesinger I.

Parkinsons Dis. 2018 Jul 5;2018:9764807. doi: 10.1155/2018/9764807. eCollection 2018. Review.

4.

Three-Dimensional Characterization of Layers of Condensed Gas Molecules Forming Universally on Hydrophobic Surfaces.

Schlesinger I, Sivan U.

J Am Chem Soc. 2018 Aug 22;140(33):10473-10481. doi: 10.1021/jacs.8b04815. Epub 2018 Aug 8.

PMID:
30040878
5.

Efficacy of Parenteral Amantadine Therapy in the Treatment of Multiple System Atrophy With Predominant Parkinsonism.

Friedberg A, Erikh I, Nassar M, Sprecher E, Schlesinger I.

Clin Neuropharmacol. 2018 Sep/Oct;41(5):160-163. doi: 10.1097/WNF.0000000000000291.

PMID:
30024441
6.

Assessing Tremor and Adverse Events in Patients With Tremor-Dominant Parkinson Disease Undergoing Focused Ultrasound Thalamotomy.

Schlesinger I, Sinai A, Zaaroor M.

JAMA Neurol. 2018 May 1;75(5):632-633. doi: 10.1001/jamaneurol.2018.0263. No abstract available.

PMID:
29582050
7.

An updated diagnostic approach to subtype definition of vascular parkinsonism - Recommendations from an expert working group.

Rektor I, Bohnen NI, Korczyn AD, Gryb V, Kumar H, Kramberger MG, de Leeuw FE, Pirtošek Z, Rektorová I, Schlesinger I, Slawek J, Valkovič P, Veselý B.

Parkinsonism Relat Disord. 2018 Apr;49:9-16. doi: 10.1016/j.parkreldis.2017.12.030. Epub 2017 Dec 29. Review.

8.

Vib-bracelet: a passive absorber for attenuating forearm tremor.

Buki E, Katz R, Zacksenhouse M, Schlesinger I.

Med Biol Eng Comput. 2018 May;56(5):923-930. doi: 10.1007/s11517-017-1742-7. Epub 2017 Nov 4.

PMID:
29101536
9.

Regulation of Surface Charge by Biological Osmolytes.

Govrin R, Schlesinger I, Tcherner S, Sivan U.

J Am Chem Soc. 2017 Oct 25;139(42):15013-15021. doi: 10.1021/jacs.7b07036. Epub 2017 Oct 16.

PMID:
28972749
10.

MRI-Guided Focused Ultrasound in Parkinson's Disease: A Review.

Schlesinger I, Sinai A, Zaaroor M.

Parkinsons Dis. 2017;2017:8124624. doi: 10.1155/2017/8124624. Epub 2017 Mar 30. Review.

11.

Magnetic resonance-guided focused ultrasound thalamotomy for tremor: a report of 30 Parkinson's disease and essential tremor cases.

Zaaroor M, Sinai A, Goldsher D, Eran A, Nassar M, Schlesinger I.

J Neurosurg. 2018 Jan;128(1):202-210. doi: 10.3171/2016.10.JNS16758. Epub 2017 Feb 24.

PMID:
28298022
12.

New Information on the Hydrophobic Interaction Revealed by Frequency Modulation AFM.

Schlesinger I, Sivan U.

Langmuir. 2017 Mar 14;33(10):2485-2496. doi: 10.1021/acs.langmuir.6b03574. Epub 2017 Feb 28.

PMID:
28218853
13.

A Trial of Focused Ultrasound Thalamotomy for Essential Tremor.

Schlesinger I, Zaaroor M.

N Engl J Med. 2016 Dec 1;375(22):2201-2. doi: 10.1056/NEJMc1612210. No abstract available.

PMID:
28103431
14.

Post-stroke dementia - a comprehensive review.

Mijajlović MD, Pavlović A, Brainin M, Heiss WD, Quinn TJ, Ihle-Hansen HB, Hermann DM, Assayag EB, Richard E, Thiel A, Kliper E, Shin YI, Kim YH, Choi S, Jung S, Lee YB, Sinanović O, Levine DA, Schlesinger I, Mead G, Milošević V, Leys D, Hagberg G, Ursin MH, Teuschl Y, Prokopenko S, Mozheyko E, Bezdenezhnykh A, Matz K, Aleksić V, Muresanu D, Korczyn AD, Bornstein NM.

BMC Med. 2017 Jan 18;15(1):11. doi: 10.1186/s12916-017-0779-7. Review.

15.

Randomized Trial of Thymectomy in Myasthenia Gravis.

Haran M, Starobin D, Schlesinger I.

N Engl J Med. 2016 Nov 17;375(20):2006. doi: 10.1056/NEJMc1611704. No abstract available.

PMID:
27959595
16.

LRRK2, GBA and SMPD1 Founder Mutations and Parkinson's Disease in Ashkenazi Jews.

Dagan E, Schlesinger I, Kurolap A, Ayoub M, Nassar M, Peretz-Aharon J, Gershoni-Baruch R.

Dement Geriatr Cogn Disord. 2016;42(1-2):1-6. doi: 10.1159/000447450. Epub 2016 Jul 23.

PMID:
27449028
17.

Closed-loop auditory feedback for the improvement of gait in patients with Parkinson's disease.

Baram Y, Aharon-Peretz J, Badarny S, Susel Z, Schlesinger I.

J Neurol Sci. 2016 Apr 15;363:104-6. doi: 10.1016/j.jns.2016.02.021. Epub 2016 Feb 10.

PMID:
27000231
18.

Autopilot for frequency-modulation atomic force microscopy.

Kuchuk K, Schlesinger I, Sivan U.

Rev Sci Instrum. 2015 Oct;86(10):103703. doi: 10.1063/1.4932939.

PMID:
26520962
19.

MRI Guided Focused Ultrasound Thalamotomy for Moderate-to-Severe Tremor in Parkinson's Disease.

Schlesinger I, Eran A, Sinai A, Erikh I, Nassar M, Goldsher D, Zaaroor M.

Parkinsons Dis. 2015;2015:219149. doi: 10.1155/2015/219149. Epub 2015 Sep 2.

20.

An ultra-low noise optical head for liquid environment atomic force microscopy.

Schlesinger I, Kuchuk K, Sivan U.

Rev Sci Instrum. 2015 Aug;86(8):083705. doi: 10.1063/1.4928497.

PMID:
26329201
21.

SMPD1 mutations and Parkinson disease.

Dagan E, Adir V, Schlesinger I, Borochowitz Z, Ayoub M, Mory A, Nassar M, Kurolap A, Aharon-Peretz J, Gershoni-Baruch R.

Parkinsonism Relat Disord. 2015 Oct;21(10):1296-7. doi: 10.1016/j.parkreldis.2015.08.019. Epub 2015 Aug 20. No abstract available.

PMID:
26318962
22.

Frequent misdiagnosis of adult polyglucosan body disease.

Hellmann MA, Kakhlon O, Landau EH, Sadeh M, Giladi N, Schlesinger I, Kidron D, Abramsky O, Reches A, Argov Z, Rabey JM, Chapman J, Rosenmann H, Gal A, Moshe Gomori J, Meiner V, Lossos A.

J Neurol. 2015 Oct;262(10):2346-51. doi: 10.1007/s00415-015-7859-4. Epub 2015 Jul 21.

PMID:
26194201
23.

The contribution of Niemann-Pick SMPD1 mutations to Parkinson disease in Ashkenazi Jews.

Dagan E, Schlesinger I, Ayoub M, Mory A, Nassar M, Kurolap A, Peretz-Aharon J, Gershoni-Baruch R.

Parkinsonism Relat Disord. 2015 Sep;21(9):1067-71. doi: 10.1016/j.parkreldis.2015.06.016. Epub 2015 Jun 19.

PMID:
26169695
24.

Restless legs syndrome in stroke patients.

Schlesinger I, Erikh I, Nassar M, Sprecher E.

Sleep Med. 2015 Aug;16(8):1006-10. doi: 10.1016/j.sleep.2014.12.027. Epub 2015 Apr 23.

PMID:
26116464
25.

Relaxation guided imagery reduces motor fluctuations in Parkinson's disease.

Schlesinger I, Benyakov O, Erikh I, Nassar M.

J Parkinsons Dis. 2014;4(3):431-6. doi: 10.3233/JPD-130338.

PMID:
24685702
26.

Handwriting as an objective tool for Parkinson's disease diagnosis.

Rosenblum S, Samuel M, Zlotnik S, Erikh I, Schlesinger I.

J Neurol. 2013 Sep;260(9):2357-61. doi: 10.1007/s00415-013-6996-x. Epub 2013 Jun 16.

PMID:
23771509
27.

Asymmetric pain processing in Parkinson's disease.

Granovsky Y, Schlesinger I, Fadel S, Erikh I, Sprecher E, Yarnitsky D.

Eur J Neurol. 2013 Oct;20(10):1375-82. doi: 10.1111/ene.12188. Epub 2013 May 24.

PMID:
23701659
28.

Detection of Alzheimer's and Parkinson's disease from exhaled breath using nanomaterial-based sensors.

Tisch U, Schlesinger I, Ionescu R, Nassar M, Axelrod N, Robertman D, Tessler Y, Azar F, Marmur A, Aharon-Peretz J, Haick H.

Nanomedicine (Lond). 2013 Jan;8(1):43-56. doi: 10.2217/nnm.12.105. Epub 2012 Oct 15.

PMID:
23067372
29.

The LRRK2 G2019S mutation is associated with Parkinson disease and concomitant non-skin cancers.

Inzelberg R, Cohen OS, Aharon-Peretz J, Schlesinger I, Gershoni-Baruch R, Djaldetti R, Nitsan Z, Ephraty L, Tunkel O, Kozlova E, Inzelberg L, Kaplan N, Fixler Mehr T, Mory A, Dagan E, Schechtman E, Friedman E, Hassin-Baer S.

Neurology. 2012 Mar 13;78(11):781-6. doi: 10.1212/WNL.0b013e318249f673. Epub 2012 Feb 8.

PMID:
22323743
30.

Medication phobia: a new cause of drug noncompliance in Parkinson disease.

Schlesinger I, Rabinowitz D.

Clin Neuropharmacol. 2011 Nov-Dec;34(6):220-3. doi: 10.1097/WNF.0b013e3182372526.

PMID:
22027928
31.

Is cognition key in paradoxical kinesia?

Schlesinger I.

Mov Disord. 2011 Feb 1;26(2):365. doi: 10.1002/mds.23433. Epub 2010 Dec 13. No abstract available.

PMID:
21412844
32.

Dopamine agonist withdrawal syndrome: the apomorphine solution.

Schlesinger I, Erikh I, Zaaroor M.

Arch Neurol. 2010 Sep;67(9):1155; author reply 1156. doi: 10.1001/archneurol.2010.220. No abstract available.

PMID:
20837868
33.

Parkinson's disease tremor is diminished with relaxation guided imagery.

Schlesinger I, Benyakov O, Erikh I, Suraiya S, Schiller Y.

Mov Disord. 2009 Oct 30;24(14):2059-62. doi: 10.1002/mds.22671.

PMID:
19768725
34.

Complex carpal malformation without a cause.

Swanger R, Faulkner C, Maldjian C, Schlesinger I, Magill R, Weinberg B.

J Pediatr Orthop B. 2009 Nov;18(6):302-3. doi: 10.1097/BPB.0b013e32832feee6.

PMID:
19701104
35.

Cardiovascular risk factors in restless legs syndrome.

Schlesinger I, Erikh I, Avizohar O, Sprecher E, Yarnitsky D.

Mov Disord. 2009 Aug 15;24(11):1587-92. doi: 10.1002/mds.22486.

PMID:
19526583
36.

Pain in progressive supranuclear palsy.

Schlesinger I, Klesier A, Yarnitsky D.

Clin Neuropharmacol. 2009 May-Jun;32(3):163-4. doi: 10.1097/WNF.0b013e31818a383c.

PMID:
19483485
37.

Uric acid in Parkinson's disease.

Schlesinger I, Schlesinger N.

Mov Disord. 2008 Sep 15;23(12):1653-7. doi: 10.1002/mds.22139. Review.

PMID:
18618666
38.

Re: Gout and risk of Parkinson disease: a prospective study.

Schlesinger I, Schlesinger N.

Neurology. 2008 Jul 1;71(1):70; author reply 70. No abstract available.

PMID:
18598007
39.

Paradoxical kinesia at war.

Schlesinger I, Erikh I, Yarnitsky D.

Mov Disord. 2007 Dec;22(16):2394-7.

PMID:
17914720
40.

Cessation of microemboli in the middle cerebral artery after a single dose of aspirin in a young patient with emboliogenic lacunar syndrome of carotid origin.

Telman G, Kouperberg E, Schlesinger I, Yarnitsky D.

Isr Med Assoc J. 2006 Oct;8(10):724-5. No abstract available.

41.

Dopamine agonists induce episodes of irresistible daytime sleepiness.

Schlesinger I, Ravin PD.

Eur Neurol. 2003;49(1):30-3.

PMID:
12464715
42.

Sleep disturbances after whiplash injury: objective and subjective findings.

Schlesinger I, Hering-Hanit R, Dagan Y.

Headache. 2001 Jun;41(6):586-9.

PMID:
11437895
43.

Lyme arthritis in a child with HIV.

Schlesinger I, Mehta H, Arlievsky N.

Orthopedics. 2001 Jun;24(6):609-10. No abstract available.

PMID:
11430747
44.

Evidence for activation of the coagulation system in migraine with aura.

Hering-Hanit R, Friedman Z, Schlesinger I, Ellis M.

Cephalalgia. 2001 Mar;21(2):137-9.

PMID:
11422096
45.

Adult polyglucosan body disease in Ashkenazi Jewish patients carrying the Tyr329Ser mutation in the glycogen-branching enzyme gene.

Lossos A, Meiner Z, Barash V, Soffer D, Schlesinger I, Abramsky O, Argov Z, Shpitzen S, Meiner V.

Ann Neurol. 1998 Dec;44(6):867-72.

PMID:
9851430
46.

Adult-onset Niemann-Pick type C disease. Clinical, biochemical, and genetic study.

Lossos A, Schlesinger I, Okon E, Abramsky O, Bargal R, Vanier MT, Zeigler M.

Arch Neurol. 1997 Dec;54(12):1536-41.

PMID:
9400363
47.

Antigliadin antibodies in migraine patients.

Schlesinger I, Hering R.

Cephalalgia. 1997 Oct;17(6):712. No abstract available.

PMID:
9350395
48.

Homocysteine levels in migraine patients.

Schlesinger I, Hering R.

Cephalalgia. 1997 Feb;17(1):46. No abstract available.

PMID:
9051337
49.

Inclusion body myositis: atypical clinical presentations.

Schlesinger I, Soffer D, Lossos A, Meiner Z, Argov Z.

Eur Neurol. 1996;36(2):89-93.

PMID:
8654492

Supplemental Content

Loading ...
Support Center